These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27766457)
1. Decreased urinary excretion of the ectodomain form of megalin (A-megalin) in children with OCRL gene mutations. Suruda C; Tsuji S; Yamanouchi S; Kimata T; Huan NT; Kurosawa H; Hirayama Y; Tsukaguchi H; Saito A; Kaneko K Pediatr Nephrol; 2017 Apr; 32(4):621-625. PubMed ID: 27766457 [TBL] [Abstract][Full Text] [Related]
2. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease. Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522 [TBL] [Abstract][Full Text] [Related]
3. Effects of Proximal Tubule Shortening on Protein Excretion in a Lowe Syndrome Model. Gliozzi ML; Espiritu EB; Shipman KE; Rbaibi Y; Long KR; Roy N; Duncan AW; Lazzara MJ; Hukriede NA; Baty CJ; Weisz OA J Am Soc Nephrol; 2020 Jan; 31(1):67-83. PubMed ID: 31676724 [TBL] [Abstract][Full Text] [Related]
4. Kidney Tubular Ablation of Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154 [TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory features of Macedonian children with OCRL mutations. Tasic V; Lozanovski VJ; Korneti P; Ristoska-Bojkovska N; Sabolic-Avramovska V; Gucev Z; Ludwig M Pediatr Nephrol; 2011 Apr; 26(4):557-62. PubMed ID: 21249396 [TBL] [Abstract][Full Text] [Related]
6. A case of Dent disease type 2 with large deletion of OCRL diagnosed after close examination of a school urinary test. Motoyoshi Y; Yabuuchi T; Miura K; Hattori M; Kiyohara K CEN Case Rep; 2022 Aug; 11(3):366-370. PubMed ID: 35098431 [TBL] [Abstract][Full Text] [Related]
8. Genotype Phenotype Correlation in Dent Disease 2 and Review of the Literature: Gianesello L; Arroyo J; Del Prete D; Priante G; Ceol M; Harris PC; Lieske JC; Anglani F Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680992 [TBL] [Abstract][Full Text] [Related]
9. Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy. Bothwell SP; Chan E; Bernardini IM; Kuo YM; Gahl WA; Nussbaum RL J Am Soc Nephrol; 2011 Mar; 22(3):443-8. PubMed ID: 21183592 [TBL] [Abstract][Full Text] [Related]
10. Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction. Bockenhauer D; Bokenkamp A; van't Hoff W; Levtchenko E; Kist-van Holthe JE; Tasic V; Ludwig M Clin J Am Soc Nephrol; 2008 Sep; 3(5):1430-6. PubMed ID: 18480301 [TBL] [Abstract][Full Text] [Related]
11. Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease. Wu G; Zhang W; Na T; Jing H; Wu H; Peng JB Am J Physiol Cell Physiol; 2012 May; 302(10):C1479-91. PubMed ID: 22378746 [TBL] [Abstract][Full Text] [Related]
12. Proteinuria in Dent disease: a review of the literature. van Berkel Y; Ludwig M; van Wijk JAE; Bökenkamp A Pediatr Nephrol; 2017 Oct; 32(10):1851-1859. PubMed ID: 27757584 [TBL] [Abstract][Full Text] [Related]
14. IPIP27A cooperates with OCRL to support endocytic traffic in the zebrafish pronephric tubule. Oltrabella F; Jackson-Crawford A; Yan G; Rixham S; Starborg T; Lowe M Hum Mol Genet; 2022 Apr; 31(8):1183-1196. PubMed ID: 34673953 [TBL] [Abstract][Full Text] [Related]
15. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. De Matteis MA; Staiano L; Emma F; Devuyst O Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993 [TBL] [Abstract][Full Text] [Related]
16. Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome. Bothwell SP; Farber LW; Hoagland A; Nussbaum RL Mamm Genome; 2010 Oct; 21(9-10):458-66. PubMed ID: 20872266 [TBL] [Abstract][Full Text] [Related]
17. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Pirruccello M; De Camilli P Trends Biochem Sci; 2012 Apr; 37(4):134-43. PubMed ID: 22381590 [TBL] [Abstract][Full Text] [Related]
18. Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells. Barnes J; Salas F; Mokhtari R; Dolstra H; Pedrosa E; Lachman HM Mol Autism; 2018; 9():44. PubMed ID: 30147856 [TBL] [Abstract][Full Text] [Related]
19. Novel pathogenic OCRL mutations and genotype-phenotype analysis of Chinese children affected by oculocerebrorenal syndrome: two cases and a literature review. Zhang Y; Deng L; Chen X; Hu Y; Chen Y; Chen K; Zhou J BMC Med Genomics; 2021 Sep; 14(1):219. PubMed ID: 34488756 [TBL] [Abstract][Full Text] [Related]
20. Novel OCRL mutations in Chinese children with Lowe syndrome. Zhang YQ; Wang F; Ding J; Yan H; Yang YL World J Pediatr; 2013 Feb; 9(1):53-7. PubMed ID: 23389333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]